JUNS
NASDAQ · Pharmaceuticals
Jupiter Neurosciences Inc
$2.97
-0.01 (-0.34%)
Open$2.97
Previous Close$2.98
Day High$3.00
Day Low$2.90
52W High$138.00
52W Low$2.88
Volume—
Avg Volume34.4K
Market Cap3.92M
P/E Ratio—
EPS$-18.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,379.1% upside
Current
$2.97
$2.97
Target
$43.93
$43.93
$31.75
$43.93 avg
$69.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 64.6K | 199.2K | 3.89M |
| Net Income | -25,643,136 | -71,121,178 | 896.5K |
| Profit Margin | -39,655.5% | -37,672.7% | 23.1% |
| EBITDA | -26,425,790 | -77,363,637 | 1.23M |
| Free Cash Flow | — | — | 754.2K |
| Rev Growth | -67.6% | -67.6% | +2.3% |
| Debt/Equity | 0.04 | 0.04 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |